Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
---|
09/23/2010 | US20100239544 Methods of treatment using electromagnetic field stimulated stem cells |
09/23/2010 | US20100239543 Pluripotent embryonic-like stem cells, compositions, methods and uses thereof |
09/23/2010 | US20100239540 Peptide Linked Cell Matrix Materials for Stem Cells and Methods of Using the Same |
09/23/2010 | US20100239532 Interferon alpha2a modified by polyethylene glycol, the preparation and use thereof |
09/23/2010 | US20100239530 Ifnar2 mutants, their production and use |
09/23/2010 | US20100239503 Calcium-binding agents induce hair growth and/or nail growth |
09/23/2010 | US20100239501 Gene sensitive to bone/joint disease and use thereof |
09/23/2010 | CA2755797A1 Improved chemical synthesis of diazaindoles by chichibabin cyclization |
09/22/2010 | EP2230308A1 Antibody molecules having specificity for human tumor necrosis factor alpha, and use thereof |
09/22/2010 | EP2230299A1 Novel cytokine ZCYTOR17 ligand |
09/22/2010 | EP2230232A1 Addition salts of tromethamine with azabiphenylaminobenzoic acid derivatives as DHODH inhibitors |
09/22/2010 | EP2229942A1 2-Aryl-propionic acids and pharmaceutical compositions containing them |
09/22/2010 | EP2229390A1 Novel imidazoý1,2-a¨pyridine and imidazoý1,2-b¨pyridazine derivatives |
09/22/2010 | EP1599464B1 Novel cyclic urea derivatives, preparation method thereof and pharmaceutical use of same as kinase inhibitors |
09/22/2010 | CN101842390A Antibodies against RAMP3 |
09/22/2010 | CN101842385A Food material for inhibiting the formation of osteoclast |
09/22/2010 | CN101842373A 6-phenyl-1h-imidazo[4,5-c]pyridine-4-carbonitrile derivatives as cathepsin inhibitors |
09/22/2010 | CN101842362A Benzothiazole compounds |
09/22/2010 | CN101842104A Method and compound for the treatment of articular diseases or articular pain, or for the treatment of skin for aesthetic or other purposes, and the method of preparation of the compound |
09/22/2010 | CN101842086A Alpha adrenergic receptor agonists for treatment of degenerative disc disease |
09/22/2010 | CN101842026A Bone-strengthening food material |
09/22/2010 | CN101838329A Anti-angiogenesis fusion protein |
09/22/2010 | CN101838254A L-arginine derivative epimedium herb flavone combination and preparation method thereof |
09/22/2010 | CN101837127A Medical use of inhibitors of glutaminyl and glutamate cyclases |
09/22/2010 | CN101837120A Method for orally administering parathyroid hormone (PTH) |
09/22/2010 | CN101837115A Steamed and applied traditional Chinese medicine for promoting recovery after restoration of prolapse of lumbar intervertebral disc |
09/22/2010 | CN101837105A Chinese medicinal composition preparation, preparation method and quality detection method |
09/22/2010 | CN101837093A Chinese medicinal composition for curing gout |
09/22/2010 | CN101837081A Specific analgesic patch |
09/22/2010 | CN101837080A Oolong spur eliminating paste |
09/22/2010 | CN101837079A Anti-inflammatory analgesic or anti-inflammatory immune medicinal composition, preparation method and application thereof |
09/22/2010 | CN101837042A Preparation method of Flos albiziae wine |
09/22/2010 | CN101836978A Solid preparation containing single crystal form |
09/22/2010 | CN101836889A Biological hollow cancellous bone screw |
09/22/2010 | CN101317942B Bone-setting alcohol |
09/22/2010 | CN101259255B Externally-applied medicament for treating wrick |
09/22/2010 | CN101181410B Chinese medicine prescription orally taken for curing osteosporosis |
09/22/2010 | CN101172103B Medicament for treating multiple diseases such as climacteric syndrome and osteoporosis of women |
09/21/2010 | US7799832 Especially tolperisone or its analogs eperisone or silperisone, or riluzole, propafenone, lidocaine, flecainide or metixen or their salts; treating pains which are accompanied by an increase in muscle tone |
09/21/2010 | US7799827 zearalenone-like macrolides, used to to inhibit nuclear factor kappa-beta (NF- kappa B) activation, as sucnscreen agents and in the treatment of inflammatory or autoimmune disorders and disorders involving malignancy or increased angiogenesis |
09/21/2010 | US7799795 chemokine receptor modulators such as N-(1-(3-(4-cyanophenyl)-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidin-2-yl)ethyl)-N-(2-(ethylsulfonyl)ethyl)-2-(4-fluoro-3-(trifluoromethyl)phenyl)-acetamide, used for the treatment of asthma, allergic and autoimmune diseases |
09/21/2010 | US7799794 Treatment for cardiovascular disease |
09/21/2010 | US7799791 osteoporosis, Paget's disease, Chagas's disease, malaria, gingival diseases, hypercalemia, bone disorders, bone cancer, metastasis pain; e.g. N-(1-cyclopentyl-2-(6-methoxy-3-oxodihydro-2H-furo[3,2-b]pyrrol-4(5H,6H,6aH)-yl)-2-oxoethyl)-4-(2-(4-methylpiperazin-1-yl)thiazol-4-yl)benzamide |
09/21/2010 | US7799775 Pyrimidine derivatives |
09/21/2010 | US7799771 solid dosage form for contraceptives and hormone replacement therapy; very low moisture content to prevent ester hydrolysis; enhanced bioavailability of 17-beta-estradiol acetate; FDA Orange book listed patent for estradiol acetate |
09/21/2010 | US7799759 albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins |
09/21/2010 | CA2458415C 24-sulfur-substituted analogs of 1.alpha.,25-dihydroxy vitamin d3 |
09/21/2010 | CA2449521C Pharmaceutical formulation, its use, and method for its manufacture |
09/21/2010 | CA2438593C Glucopyranosyloxypyrazole derivatives and medicinal use thereof |
09/21/2010 | CA2437950C Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical |
09/21/2010 | CA2436225C N-(arylsulphonyl)beta-amino acid derivatives comprising a substituted aminomethyl group, process for preparing them and pharmaceutical compositions containing them |
09/21/2010 | CA2434178C Substituted amine derivatives and methods of use |
09/21/2010 | CA2429308C Novel lactam-substituted pyrazolopyridine derivatives |
09/21/2010 | CA2428019C Estrogen receptor modulators |
09/21/2010 | CA2417148C Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation |
09/21/2010 | CA2401502C Carboxylic acid derivatives as ip antagonists |
09/21/2010 | CA2386549C Polymorphic b form of 3-(cyclopropylmethoxy)-4-[4-(methylsulfonyl)phenyl]-5,5-dimethyl-5h-furan-2-one |
09/21/2010 | CA2306692C Dipeptide apoptosis inhibitors and the use thereof |
09/16/2010 | WO2010104577A2 Methods and kits for treating joints and soft tissues |
09/16/2010 | WO2010104576A1 Methods for treating joints and discs with a carrier matrix and cells |
09/16/2010 | WO2010104205A1 7-cycloalkylaminoquinolones as gsk-3 inhibitors |
09/16/2010 | WO2010104187A1 Steroid compound |
09/16/2010 | WO2010104079A1 Composition for reducing bone fracture risk and/or preventing bone fracture |
09/16/2010 | WO2010104024A1 Piperazine compound capable of inhibiting prostaglandin d synthase |
09/16/2010 | WO2010103843A1 External preparation containing analgesic/anti-inflammatory agent |
09/16/2010 | WO2010103429A1 1,1-(Dimethyl-Ethylamino)-2-Hydroxy-Propoxy]-Ethyl}-3-Methyl-Biphenyl-4- Carboxylic Acid Derivatives As Calcium Receptor Antagonists |
09/16/2010 | WO2010102958A1 4-oxadiazol-2 -yl- indazoles as inhibitors of p13 kinases |
09/16/2010 | WO2010102825A1 Addition salts of tromethamine with azabiphenylaminobenzoic acid derivatives as dhodh inhibitors |
09/16/2010 | US20100234966 Bone repair or augmentation device |
09/16/2010 | US20100234470 Instillation Administration of Capsaicinoids for the Treatment of Pain |
09/16/2010 | US20100234449 Immunostimulatory Method |
09/16/2010 | US20100234448 In vivo production of small interfering rnas that mediate gene silencing |
09/16/2010 | US20100234441 Novel compounds |
09/16/2010 | US20100234440 Novel crystal of substituted phenylalkanoic acid ester and process for producing the same |
09/16/2010 | US20100234435 Cycloalkylamino acid derivatives |
09/16/2010 | US20100234416 Use of huperzine for disorders |
09/16/2010 | US20100234409 Amino cyclopentyl heterocyclic and carbocyclic modulators of chemokine receptor activity |
09/16/2010 | US20100234404 P-38 Kinase Inhibitors |
09/16/2010 | US20100234382 Composition comprising a pde4 inhibitor and a pde5 inhibitor |
09/16/2010 | US20100234373 Bis-aryl amide compounds and methods of use |
09/16/2010 | US20100234367 7-cycloalkylaminoquinolones as gsk-3 inhibitors |
09/16/2010 | US20100234356 Compounds useful as chemokine receptor antagonists |
09/16/2010 | US20100234353 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
09/16/2010 | US20100234334 Nitric oxide releasing steroids |
09/16/2010 | US20100234326 Composition for decelerating the aging in the organism and for extending the life time thereof and the use of said composition |
09/16/2010 | US20100234322 Treatment of osteoarthritis |
09/16/2010 | US20100234317 Use of difructose anhydride-containing composition |
09/16/2010 | US20100234296 Food material for inhibiting osteoclastogenesis |
09/16/2010 | US20100234295 Treating Alzheimer's Disease And Osteoporosis And Reducing Aging |
09/16/2010 | US20100234277 Coadministration of alpha-fetoprotein and a disease modifying anti-rheumatic drug for treating inflammatory arthritic disease |
09/16/2010 | US20100233810 In vivo production of small interfering rnas that mediate gene silencing |
09/16/2010 | US20100233722 Methods for determining the biological effect and/or activity of r pharmaceutical compositions based on their effect on the methylation status of the DNA |
09/16/2010 | US20100233290 Use of difructose anhydride-containing composition |
09/16/2010 | US20100233269 Mineralized polymer particles and the method for their production |
09/16/2010 | US20100233247 Dressing Material Comprising Active Substances |
09/16/2010 | US20100233234 System and method for a hydrogel and hydrogel composite for cartilage repair applications |
09/16/2010 | US20100233169 Methods for treating obesity using fibroblast growth factor-Like polypeptides |
09/16/2010 | US20100233158 Induction of immune tolerance |
09/16/2010 | US20100233155 Humanized anti-ccr2 antibodies and methods of use therefor |
09/16/2010 | US20100233154 Targeted binding agents directed to heparanase and uses thereof 463 |